Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Statin adherence and LDL cholesterol levels. Should we assess adherence prior to statin upgrade?

Vodonos A, Ostapenko I, Toledano R, Henkin Y, Zahger D, Wolak T, Sherf M, Novack V.

Eur J Intern Med. 2015 May;26(4):268-72. doi: 10.1016/j.ejim.2015.02.014. Epub 2015 Mar 11.

PMID:
25770073
2.

Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.

Munkhaugen J, Sverre E, Otterstad JE, Peersen K, Gjertsen E, Perk J, Gullestad L, Moum T, Dammen T, Husebye E.

Eur J Prev Cardiol. 2017 Jun;24(9):981-989. doi: 10.1177/2047487317693134. Epub 2017 Feb 14.

PMID:
28196429
3.

Adherence to statins and LDL-cholesterol goal attainment.

Chi MD, Vansomphone SS, Liu IL, Cheetham C, Green KR, Scott RD, Reynolds K.

Am J Manag Care. 2014 Apr 1;20(4):e105-12.

4.

Association between statin adherence and cholesterol level reduction from baseline in a veteran population.

Kazerooni R, Watanabe JH, Bounthavong M.

Pharmacotherapy. 2013 Oct;33(10):1044-52. doi: 10.1002/phar.1305. Epub 2013 Jun 6.

PMID:
23744794
5.

Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.

Fox KM, Tai MH, Kostev K, Hatz M, Qian Y, Laufs U.

Clin Res Cardiol. 2018 May;107(5):380-388. doi: 10.1007/s00392-017-1193-z. Epub 2017 Dec 22.

6.

LDL cholesterol response and statin adherence among high-risk patients initiating treatment.

Vupputuri S, Joski PJ, Kilpatrick R, Woolley JM, Robinson BE, Farkouh ME, Yun H, Safford MM, Muntner P.

Am J Manag Care. 2016 Mar 1;22(3):e106-15.

7.
8.

Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.

Leibowitz M, Karpati T, Cohen-Stavi CJ, Feldman BS, Hoshen M, Bitterman H, Suissa S, Balicer RD.

JAMA Intern Med. 2016 Aug 1;176(8):1105-13. doi: 10.1001/jamainternmed.2016.2751.

PMID:
27322095
9.

Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting.

Simpson RJ Jr, Tunceli K, Ramey DR, Neff DR, Kern DM, Hsieh HM, Wertz DA, Stephenson JJ, Marrett E, Tomassini JE, Jacobson TA.

J Clin Lipidol. 2013 Sep-Oct;7(5):399-407. doi: 10.1016/j.jacl.2013.06.002. Epub 2013 Jun 18.

PMID:
24079280
10.

Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.

Shalev V, Goldshtein I, Halpern Y, Chodick G.

Pharmacotherapy. 2014 Jan;34(1):1-8. doi: 10.1002/phar.1326. Epub 2013 Jul 8.

PMID:
23836549
11.

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.

Okerson T, Patel J, DiMario S, Burton T, Seare J, Harrison DJ.

J Am Heart Assoc. 2017 Mar 17;6(3). pii: e004909. doi: 10.1161/JAHA.116.004909.

12.

The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial.

Zhao SP, Yu BL, Peng DQ, Huo Y.

Atherosclerosis. 2014 Apr;233(2):707-12. doi: 10.1016/j.atherosclerosis.2013.12.003. Epub 2014 Jan 8.

PMID:
24603217
13.

Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans.

Kim HS, Lee H, Lee SH, Jeong YJ, Kim TM, Yang SJ, Baik SJ, Kim H, Lee SH, Cho JH, Choi IY, Yoon KH, Kim JH.

Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):272-278. doi: 10.1111/bcpt.12765. Epub 2017 Jul 9.

14.

Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients.

Grover A, Rehan HS, Gupta LK, Yadav M.

Indian Heart J. 2017 Jan - Feb;69(1):6-10. doi: 10.1016/j.ihj.2016.07.007. Epub 2016 Aug 1.

15.

Blood pressure and lipid target adherence in Korean patients receiving angiotensin II receptor blockers/statin regimens.

Kim HJ, Kim E, Min KB, Min JY.

Curr Med Res Opin. 2017 Feb;33(2):385-390. doi: 10.1080/03007995.2016.1257982. Epub 2016 Dec 2.

PMID:
27819152
16.

Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care.

Guglielmi V, Bellia A, Pecchioli S, Della-Morte D, Parretti D, Cricelli I, Medea G, Sbraccia P, Lauro D, Cricelli C, Lapi F.

Atherosclerosis. 2017 Aug;263:36-41. doi: 10.1016/j.atherosclerosis.2017.05.018. Epub 2017 May 20.

PMID:
28599257
17.
18.

Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.

Bermingham M, Hayden J, Dawkins I, Miwa S, Gibson D, McDonald K, Ledwidge M.

Clin Ther. 2011 Sep;33(9):1180-9. doi: 10.1016/j.clinthera.2011.07.007. Epub 2011 Aug 12.

PMID:
21840055
19.

Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic.

Ladova K, Matoulkova P, Zadak Z, Macek K, Vyroubal P, Vlcek J, Morisky DE.

J Eval Clin Pract. 2014 Oct;20(5):671-7. doi: 10.1111/jep.12201. Epub 2014 Jun 11.

PMID:
24917035
20.

Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol.

Harrison TN, Scott RD, Cheetham TC, Chang SC, Hsu JY, Wei R, Ling Grant DS, Boklage SH, Romo-LeTourneau V, Reynolds K.

Cardiovasc Drugs Ther. 2018 Aug;32(4):397-404. doi: 10.1007/s10557-018-6810-1.

Supplemental Content

Support Center